FDA Approved: VALSARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for valsartan, a generic angiotensin II receptor blocker, for approved labeling/strengths.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)